Shares in Intel (INTC) stock have fallen nearly 10% in the last five days, including a 5% slip after the opening bell on Wednesday. Following a massive rally driven by surging demand for server CPUs in the agentic AI boom, the chipmaker’s shares have stalled in the last month. Despite a solid earnings report in June 2026, the company remains at the heart of AI jitters that continue to rattle Wall Street. Indeed, Intel shares have surged roughly 162% this year after investors grew more optimistic about the chipmaker’s turnaround and AI prospects, although the stock has pulled back roughly 26% from its June high.
Semiconductor companies were falling sharply on Tuesday amid higher oil prices and bond yields. The 30-year U.S. Treasury yield settled at a 19-year high of 5.310% and was at 5.288% on Tuesday afternoon. Intel, AMD, Nvidia and several other chip stocks have taken a hit, which may lessen the worries of a specific spark for INTC’s recent decline.
Fortunately, all the big names in AI have enjoyed sizable gains over from July 29 through the beginning of this week. Nvidia, has jumped 18%, Intel has climbed 26%, and Micron is up 37% in that span. Furthermore, there are signs coming from internally that show a potential big move for Intel is ahead. The company’s CEO Lip-Bu Tan has made a major purchase of INTC stock in the last week, buying 105,263 Intel (INTC) shares for $95 each on Aug. 11. The insider buy comes at a pivotal time for Intel. The company just raised nearly $20 billion in fresh equity as it ramps up spending on manufacturing and tries to turn its foundry business into a credible alternative to Taiwan Semiconductor Manufacturing (TSM).
Also Read: Micron Stock vs. SK Hynix: Which AI Chip Stock Will Surge More?
On Wall Street, firms are still paying close attention to Intel stock’s recent volatility when determing INTC forecasts. Despite concerns about dilution, analysts maintain a cautious “Hold” rating, with an average price target suggesting an 18.4% upside potential if Intel successfully executes its growth strategy. Rosenblatt and JP Morgan lean bearish with Sell and Underweight ratings, respectively. On the other hand, Goldman Sachs, with a Neutral rating, suggests a higher price target of $150.